We are live on
!
Find out more
Celularity
CELU
CELU
37 hedge funds and large institutions have $2.06M invested in Celularity in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.47% less ownership
Funds ownership: 1.9% → 0.44% (-1.5%)
18% less funds holding
Funds holding: 45 → 37 (-8)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
74% less capital invested
Capital invested by funds: $8.02M → $2.06M (-$5.96M)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
37
Holders Change
-8
Holders Change %
-17.78%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
7
Reduced
13
Closed
8
Calls
$81K
Puts
–
Net Calls
+$81K
Net Calls Change
+$10K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$65.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.8K |
| 4 |
Morgan Stanley
New York
|
+$4.88K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.09K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$1.04M |
| 2 |
Millennium Management
New York
|
-$157K |
| 3 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
-$27.7K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$13.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.86K |
